Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network
Authors:
- 22 January 2016
- journal article
- Published by Springer Nature in Immunologic Research
- Vol. 64 (3) , 736-753
Abstract
Primary immunodeficiencies (PI) are defects of the immune system that cause severe, sometimes life-threatening, infections if not diagnosed and treated appropriately. Many patients with PI are undiagnosed, under-diagnosed, or misdiagnosed. To raise awareness and assure earliest diagnosis, appropriate treatment, and proper care management, the Jeffrey Modell Foundation (JMF) implemented a physician education and public awareness program beginning in 2003. Data are requested annually from physician experts within the Jeffrey Modell Centers Network (JMCN), consisting of 602 expert physicians, at 253 academic institutions, in 206 cities, and 84 countries spanning six continents. Center Directors reported on patients’ specific PI defects and treatment modalities including immunoglobulins, transplantation, and gene therapy as well as data on gender and age. Center Directors also provided physician-reported patient outcomes as well as pre- and post-diagnosis differences. Costs were assigned to these factors. In collaboration with the Network, JMF advocated, funded, and implemented population-based newborn screening for severe combined immunodeficiency and T cell lymphopenia, covering 96.2 % of all newborns in the US. Finally, 21 JMF Centers participated in a polio surveillance study of patients with PI who either received or have been exposed to the oral polio vaccine. These initiatives have led to an overall better understanding of the immune system and will continue to improve quality of life for those with PI.Keywords
This publication has 31 references indexed in Scilit:
- The cup runneth over: lessons from the ever-expanding pool of primary immunodeficiency diseasesNature Reviews Immunology, 2013
- Outcome of hematopoietic stem cell transplantation for adenosine deaminase–deficient severe combined immunodeficiencyBlood, 2012
- Adult Primary Immune Deficiency: What Are We Missing?The American Journal of Medicine, 2012
- Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: The winner is T-cell receptor excision circlesJournal of Allergy and Clinical Immunology, 2012
- A Markov model to analyze cost-effectiveness of screening for severe combined immunodeficiency (SCID)Molecular Genetics and Metabolism, 2011
- Systematic Evidence Review of Newborn Screening and Treatment of Severe Combined ImmunodeficiencyPediatrics, 2010
- Outcomes of patients with severe combined immunodeficiency treated with hematopoietic stem cell transplantation with and without preconditioningJournal of Allergy and Clinical Immunology, 2009
- Health Care Cost Growth Among The Privately InsuredHealth Affairs, 2009
- Molecular defects in T- and B-cell primary immunodeficiency diseasesNature Reviews Immunology, 2005
- Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1999